JULIAN BAKER Insider Trading $IDRA IDERA PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JULIAN BAKER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JULIAN BAKER. JULIAN BAKER is Director in INCYTE CORP ($INCY) and Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA).
JULIAN BAKER in IDERA PHARMACEUTICALS, INC.
Trading Symbol: IDRAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JULIAN BAKER: Director
Holdings: 1,017,950 shares
Current Value: $1,588,002
Latest Transaction: Jan 05 2017
$IDRA Market Capitalization: $230.34M
$IDRA Previous Close: $1.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JULIAN BAKER in IDERA PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IDRA, INCY, GEVA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 05 2017 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 1.50 | 14,169 | 21,254 | 125,179 | 111 K to 125.2 K (+12.76 %) |
Jan 05 2017 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 1.50 | 14,169 | 21,254 | 9,323,502 | 9.3 M to 9.3 M (+0.15 %) |
Jan 05 2017 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 1.50 | 14,169 | 21,254 | 1,017,950 | 1 M to 1 M (+1.41 %) |
Oct 11 2016 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Buy | P | 2.00 | 2,928,596 | 5,857,192 | 9,309,333 | 6.4 M to 9.3 M (+45.90 %) |
Oct 11 2016 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Buy | P | 2.00 | 321,404 | 642,808 | 1,003,781 | 682.4 K to 1 M (+47.10 %) |
Oct 05 2016 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 2.56 | 8,299 | 21,245 | 111,010 | 102.7 K to 111 K (+8.08 %) |
Oct 05 2016 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 2.56 | 8,299 | 21,245 | 6,380,737 | 6.4 M to 6.4 M (+0.13 %) |
Oct 05 2016 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 2.56 | 8,299 | 21,245 | 682,377 | 674.1 K to 682.4 K (+1.23 %) |
Jul 06 2016 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 1.63 | 13,038 | 21,252 | 102,711 | 89.7 K to 102.7 K (+14.54 %) |
Jul 06 2016 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 1.63 | 13,038 | 21,252 | 6,372,438 | 6.4 M to 6.4 M (+0.21 %) |
Jul 06 2016 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 1.63 | 13,038 | 21,252 | 674,078 | 661 K to 674.1 K (+1.97 %) |
Jun 15 2016 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Option Exercise | A | 1.44 | 70,000 | 100,800 | 70,000 | |
Apr 05 2016 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 1.97 | 10,788 | 21,252 | 89,673 | 78.9 K to 89.7 K (+13.68 %) |
Apr 05 2016 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 1.97 | 10,788 | 21,252 | 6,359,400 | 6.3 M to 6.4 M (+0.17 %) |
Apr 05 2016 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 1.97 | 10,788 | 21,252 | 661,040 | 650.3 K to 661 K (+1.66 %) |
Jan 06 2016 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 3.00 | 7,082 | 21,246 | 78,885 | 71.8 K to 78.9 K (+9.86 %) |
Jan 06 2016 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 3.00 | 7,082 | 21,246 | 6,348,612 | 6.3 M to 6.3 M (+0.11 %) |
Jan 06 2016 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 3.00 | 7,082 | 21,246 | 650,252 | 643.2 K to 650.3 K (+1.10 %) |
Oct 05 2015 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 3.06 | 6,945 | 21,252 | 71,803 | 64.9 K to 71.8 K (+10.71 %) |
Oct 05 2015 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 3.06 | 6,945 | 21,252 | 6,341,530 | 6.3 M to 6.3 M (+0.11 %) |
Oct 05 2015 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 3.06 | 6,945 | 21,252 | 643,170 | 636.2 K to 643.2 K (+1.09 %) |
Jul 06 2015 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 3.66 | 5,260 | 19,252 | 64,858 | 59.6 K to 64.9 K (+8.83 %) |
Jul 06 2015 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 3.66 | 5,260 | 19,252 | 6,334,585 | 6.3 M to 6.3 M (+0.08 %) |
Jul 06 2015 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 3.66 | 5,260 | 19,252 | 636,225 | 631 K to 636.2 K (+0.83 %) |
Jun 10 2015 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Option Exercise | A | 3.59 | 70,000 | 251,300 | 70,000 | |
Apr 02 2015 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 3.52 | 5,470 | 19,254 | 59,598 | 54.1 K to 59.6 K (+10.11 %) |
Apr 02 2015 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 3.52 | 5,470 | 19,254 | 6,329,325 | 6.3 M to 6.3 M (+0.09 %) |
Apr 02 2015 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 3.52 | 5,470 | 19,254 | 630,965 | 625.5 K to 631 K (+0.87 %) |
Page: 1